Contact Information: Public and Investor Relations: Mercom Capital Group, llc tel: 1.512.828.6645 e-mail: Email Contact
PrecisionRx Technologies & Services Announces Medication Compliance Program for Canada
Signs Agreement to Provide ALR Technologies' Compliance Reminder Products to Pharmacies and Patients
| Quelle: ALR Technologies, Inc.
WINSTON-SALEM, NC -- (MARKET WIRE) -- March 12, 2007 --ALR Technologies, Inc. (OTCBB : ALRT )
announces that PrecisionRx Technologies & Services Inc. will begin
providing ALR Technologies' medication
compliance products to pharmacies and patients in Canada beginning in
the second quarter of 2007. PrecisionRx Technologies & Services will be
working in partnership with Gennium Pharmaceutique, a
leading provider of generic medications and other services to pharmacies in
Quebec.
PrecisionRx Technologies & Services, working with Gennium Pharmaceutique,
will become the first provider of medications in Canada to offer this
valuable service, according to Connie Casola, the Director of Professional
Services for Gennium Pharmaceutique. "We are pleased to be working with ALR
Technologies on this much needed service to people who are taking
medications for chronic conditions. The ALR products bring an affordable
and easy to use solution to the long known problem of patient
noncompliance."
"Patient noncompliance brings about increasing health problems and
escalating costs to our health care system," adds Casola. "We are pleased
to be the first company to offer a program throughout Canada to help
address this serious issue."
About Gennium Pharmaceutique and PrecisionRx Technologies & Services, Inc.
Gennium Pharmaceutique is a leading provider of generic medications to
pharmacies and healthcare systems in Quebec, and is the exclusive
distributor of Genpharm generic
medication in the Province to retail pharmacies. Entirely
Quebec owned and managed, Gennium Pharmaceutique prides itself on being a
provider of value added services to complement medical healthcare regimes.
With 100% dedication, the Gennium Pharmaceutique team is committed to
exceed the needs and expectations of its partner pharmacists, while
remaining on the cutting edge of both pharmaceutical innovation and
professional service. To do so, Gennium Pharmaceutique depends on its
exceptional sales representatives and its wide range of exclusive turnkey
services. PrecisionRx Technologies & Services Inc. is a company that
specializes in professional services to pharmacies and hospitals in Canada.
For more information, please contact: conniec@genn.ca.
About ALR Technologies, Inc.
ALR Technologies, Inc. (ALRT) specializes in health and disease management
products and services. ALRT designs and manufactures health management
compliance products and monitoring and intervention systems to meet the
needs of several targeted user groups. ALRT's system, branded Constant Health
Companion™, responds to a serious gap in standard disease management
practices in the US. It provides for continued compliance supervision to
help keep people healthy, whether they are recovering from an organ
transplant, suffer from diabetes, heart disease, asthma, COPD, or live with
other serious conditions. More information on ALR Technologies and its
products can be found at http://www.alrt.com. More information about the
Constant Health Companion can be found at:
http://www.alrt.com/products/alrt500.html.
This release contains certain "forward-looking statements" relating to ALR
Technologies' business, and these statements reflect the current views of
ALR Technologies with respect to future events and are subject to certain
risks, uncertainties and assumptions. When used, the words "estimate,"
"expect," "anticipate," "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors that
could cause the actual results, performance or achievements of ALR
Technologies and its products to be materially different from any future
results, performances or achievements that may be expressed or implied by
such forward-looking statements. Further management discussions of risks
and uncertainties can be found in the company's quarterly filings with the
Securities Exchange Commission.